News & Updates

In the phase III SUNRISE trial, tezepelumab significantly reduces daily maintenance oral corticosteroid (OCS) dose while maintaining asthma control in adults with severe OCS-dependent asthma, despite early study termination and the smaller-than-planned sample size.

A small observational study involving patients presenting to the emergency department (ED) with an acute asthma attack has noted therapeutic benefits with adjunct acupuncture, resulting in fewer inpatient admissions and rapid improvement in peak expiratory flow rate (PEFR).

A population-based study of individuals with chronic obstructive pulmonary disease (COPD) in Singapore shows substantial and rising healthcare costs.

A high neutrophil-to-lymphocyte ratio (NLR; ≥4.75) at baseline appears to contribute to an elevated risk of developing severe checkpoint inhibitor pneumonitis (CIP) in patients with nonsmall cell lung cancer (NSCLC), suggests a study.

Eccentric and concentric training similarly improve walking distance in severe COVID-19 survivors in the CovExc trial.

First-line treatment with lorlatinib demonstrates long-term survival benefits in patients with advanced anaplastic lymphoma kinase (ALK)-positive nonsmall cell lung cancer (NSCLC), as shown in the 7-year update from the phase III CROWN study.